{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":38,"n_cols":5,"rows_kept":38,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[13,2,13,3],[17,2,17,3],[25,2,25,3],[25,4,25,5],[26,2,26,3],[26,4,26,5],[27,2,27,3],[29,2,29,3],[31,2,31,3],[32,2,32,3],[33,2,33,3],[34,2,34,3],[35,2,35,3],[36,2,36,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910132344003321"]
[null,null,"Titolo",null,"Novel antimicrobial agents and strategies / / edited by David A. Phoenix, Frederick Harris and Sarah R. Dennison ; contributors Waqar Ahmed [and thirty one others]"]
[null,null,"Pubbl/distr/stampa",null,"Weinheim, Germany : , : Wiley-VCH, , 2015"]
[{"$nulls":4},"©2015"]
[null,null,"ISBN",null,"3-527-67615-5"]
[{"$nulls":4},"3-527-67613-9"]
[{"$nulls":4},"3-527-67614-7"]
[null,null,"Descrizione fisica",null,"1 online resource (439 p.)"]
[null,null,"Disciplina",null,"614.48"]
[null,null,"Soggetti",null,"Disinfection and disinfectants"]
[{"$nulls":4},"Anti-infective agents"]
[{"$nulls":4},"Sterilization"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Novel Antimicrobial Agents and Strategies; Contents; List of Contributors; Preface; Chapter 1 The Problem of Microbial Drug Resistance; 1.1 Introduction; 1.2 History of the Origins, Development, and Use of Conventional Antibiotics; 1.3 Problems of Antibiotic Resistance; 1.4 Multiple Drug-Resistant (MDR), Extensively Drug-Resistant (XDR), and Pan-Drug-Resistant (PDR) Organisms; 1.5 MDR Mechanisms of Major Pathogens; 1.6 Antimicrobial Stewardship Programs; 1.7 Discussion; Acknowledgment; References; Chapter 2 Conventional Antibiotics -- Revitalized by New Agents; 2.1 Introduction"]
[{"$nulls":4},"2.2 Conventional Antibiotics2.3 The Principles of Combination Antibiotic Therapy; 2.4 Antibiotic Resistance Breakers: Revitalize Conventional Antibiotics; 2.4.1 β-Lactamase Inhibitors; 2.4.2 Aminoglycoside-Modifying Enzyme Inhibitors; 2.4.3 Antibiotic Efflux Pumps Inhibitors; 2.4.4 Synergy Associated with Bacterial Membrane Permeators; 2.5 Discussion; Acknowledgments; References; Chapter 3 Developing Novel Bacterial Targets: Carbonic Anhydrases as Antibacterial Drug Targets; 3.1 Introduction; 3.2 Carbonic Anhydrases; 3.3 CA Inhibitors; 3.4 Classes of CAs Present in Bacteria"]
[{"$nulls":4},"3.5 Pathogenic Bacterial CAs3.6 α-CAs in Pathogenic Bacteria; 3.7 β-"]
[{"$nulls":4},"CAs in Pathogenic Bacteria; 3.8 γ-CAs from Pathogenic Bacteria; 3.9 Conclusions; References; Chapter 4 Magainins -- A Model for Development of Eukaryotic Antimicrobial Peptides (AMPs); 4.1 Introduction; 4.2 Magainins and Their Antimicrobial Action; 4.3 Magainins as Antibiotics; 4.4 Other Antimicrobial Uses of Magainins; 4.5 Future Prospects for Magainins; References; Chapter 5 Antimicrobial Peptides from Prokaryotes; 5.1 Introduction; 5.2 Bacteriocins; 5.2.1 Microcins -- Peptide Bacteriocins from Gram-Negative Bacteria"]
[{"$nulls":4},"5.2.2 Lanthibiotics -- Post-translationally Modified Peptides from Gram-Positive Bacteria5.2.3 Non-modified Peptides from Gram-Positive Bacteria; 5.3 Applications of Prokaryotic AMPs; 5.3.1 Food Biopreservation; 5.3.2 Bacteriocinogenic Probiotics; 5.3.3 Clinical Application; 5.3.4 Applications in Dental Care; 5.4 Development and Discovery of Novel AMP; References; Chapter 6 Peptidomimetics as Antimicrobial Agents; 6.1 Introduction; 6.2 Antimicrobial Peptidomimetics; 6.2.1 Peptoids; 6.2.2 β-Peptides; 6.2.3 Arylamides; 6.2.4 β-Peptoid--Peptide Hybrid Oligomers"]
[{"$nulls":4},"6.2.5 Oligourea and γ 4-Peptide-Based Oligomers6.2.6 AApeptides; 6.2.6.1 α-AApeptides; 6.2.6.2 γ-AApeptides; 6.3 Discussion; Acknowledgments; References; Chapter 7 Synthetic Biology and Therapies for Infectious Diseases; 7.1 Current Challenges in the Treatment of Infectious Diseases; 7.2 Introduction to Synthetic Biology; 7.3 Vaccinology; 7.3.1 Genetic Engineering and Vaccine Development; 7.3.2 Rational Antigen Design Through Reverse Vaccinology; 7.4 Bacteriophages: A Re-emerging Solution?; 7.4.1 A Brief History of Bacteriophages"]
[{"$nulls":4},"7.4.2 Addressing the Problem of the Restricted Host Range of Phages"]
[null,null,null,"Sommario/riassunto","By integrating knowledge from pharmacology, microbiology, molecular medicine, and engineering, researchers from Europe, the U.S. and Asia cover a broad spectrum of current and potential antimicrobial medications and treatments. The result is a comprehensive survey ranging from small-molecule antibiotics to antimicrobial peptides and their engineered mimetics, from enzymes to nucleic acid therapeutics, from metallic nanoparticles to photo- and sonosensitizers and to phage therapy. In each case, the therapeutic approaches are compared in terms of their mechanisms, likelihood to induce resistance"]
[null,"2.","Record Nr.",null,"UNISANNIOTO00632194"]
[null,null,"Titolo",null,"Antitrust fra diritto nazionale e diritto comunitario : atti del 3. Convegno di Treviso, 15-16 maggio 1997 / a cura di Enrico Adriano Raffaelli"]
[null,null,"Pubbl/distr/stampa",null,"Milano, : Giuffrè"]
[{"$nulls":4},"Bruxelles, : Bruylant, 1998"]
[null,null,"ISBN",null,"280271080X"]
[{"$nulls":4},"8814067317"]
[null,null,"Descrizione fisica",null,"XII, 560 p. ; 24 cm."]
[null,null,"Disciplina",null,"343.07"]
[null,null,"Soggetti",null,"Concorrenza - Diritto comunitario"]
[null,null,"Collocazione",null,"D         (C) 22                  766"]
[null,null,"Lingua di pubblicazione",null,"Molteplice"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]